drugset

drugset / Trial / NCT00122694

Modification of Chronic Inflammation by Inhaled Carbon Monoxide in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)

NCT00122694 ↗

Phase 2 Completed 20 enrolled Groningen Research Institute for Asthma and COPD Stichting Astma Bestrijding, The Netherlands · collab

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine whether carbon monoxide is effective in the treatment of stable COPD.

Timeline

Start: 2005-01
Primary completion: —
Completion: 2006-03

Publications

Bathoorn E, Slebos DJ, Postma DS, Koeter GH, van Oosterhout AJ, van der Toorn M, Boezen HM, Kerstjens HA. Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study. Eur Respir J. 2007 Dec;30(6):1131-7. doi: 10.1183/09031936.00163206. Epub 2007 Aug 22.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Carbon Monoxide	Other / unclassified	100 ppm	Inhaled
Subject	Carbon Monoxide	Other / unclassified	125 ppm	Inhaled

Indications